NLS Pharmaceutics AG Cash Flow Reinvestment Rate
Latest as of June 2019:
0.00x
NLS Pharmaceutics AG cash flow reinvestment rate. NLS Pharmaceutics AG (NLSP) has a Cash Flow Reinvestment Rate of 0.00x as of June 2019, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $712.96K. Explore NLS Pharmaceutics AG cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$712.96K
USD
Capital Expenditures
$0.00
USD
NLS Pharmaceutics AG Cash Flow Reinvestment Rate by Year (None–None)
NLS Pharmaceutics AG cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for NLS Pharmaceutics AG. For the full cash flow conversion analysis, see cash flow conversion of NLS Pharmaceutics AG.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow